Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$49.38 - $63.75 $70,020 - $90,397
-1,418 Reduced 4.59%
29,446 $1.83 Million
Q3 2023

Nov 13, 2023

BUY
$48.64 - $62.51 $1,702 - $2,187
35 Added 0.11%
30,864 $1.73 Million
Q2 2023

Aug 14, 2023

SELL
$47.99 - $60.21 $244,796 - $307,131
-5,101 Reduced 14.2%
30,829 $1.56 Million
Q1 2023

May 08, 2023

BUY
$52.6 - $67.34 $263 - $336
5 Added 0.01%
35,930 $1.96 Million
Q4 2022

Feb 14, 2023

SELL
$59.56 - $76.6 $7,325 - $9,421
-123 Reduced 0.34%
35,925 $2.25 Million
Q3 2022

Nov 10, 2022

BUY
$57.96 - $78.12 $2.09 Million - $2.82 Million
36,048 New
36,048 $2.54 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.